技术与方法 |
|
|
|
|
血栓调节蛋白化学发光免疫分析检测方法的建立* |
李帅鹏1,任和1,安展飞2,杨艳坤1,白仲虎1,**() |
1 江南大学 粮食发酵工艺与技术国家工程实验室 无锡 214122 2 江苏拜明生物技术有限公司 盐城 224005 |
|
The Development of Chemiluminescence Immunoassay Detection Method for Thrombomodulin |
LI Shuai-peng1,REN He1,AN Zhan-fei2,YANG Yan-kun1,BAI Zhong-hu1,**() |
1 National Engineering Laboratory of Grain Fermentation Technology, Jiangnan University, Wuxi 214122, China 2 Jiangsu Baiming Biotechnology Co., Ltd., Yancheng 224005, China |
引用本文:
李帅鹏,任和,安展飞,杨艳坤,白仲虎. 血栓调节蛋白化学发光免疫分析检测方法的建立*[J]. 中国生物工程杂志, 2021, 41(4): 30-36.
LI Shuai-peng,REN He,AN Zhan-fei,YANG Yan-kun,BAI Zhong-hu. The Development of Chemiluminescence Immunoassay Detection Method for Thrombomodulin. China Biotechnology, 2021, 41(4): 30-36.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2101031
或
https://manu60.magtech.com.cn/biotech/CN/Y2021/V41/I4/30
|
[1] |
Maruyama I, Bell C E, Majerus P W. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. Journal of Cell Biology, 1985,101(2):363-371.
|
[2] |
郑娜娜. 血栓调节蛋白对肺癌细胞致瘤性和迁移的抑制作用及其机制. 苏州: 苏州大学, 2016.
|
|
Zheng N N. Thrombomodulin inhibits tumorigenesis and migration of lung cancer cells and its mechanism. Suzhou: Soochow University, 2016.
|
[3] |
Morser J. Thrombomodulin links coagulation to inflammation and immunity. Current Drug Targets, 2012,13(3):421-431.
pmid: 22206250
|
[4] |
Dittman W A, Majerus P W. Structure and function of thrombomodulin: a natural anticoagulant. Blood, 1990,75(2):329-336.
|
[5] |
Conway E M. The type XIV family of C-type lectin-like domain (CTLD) containing proteins. Current Drug Targets, 2012,13(3):409-410.
pmid: 22206248
|
[6] |
Loghmani H, Conway E M. Exploring traditional and nontraditional roles for thrombomodulin. Blood, 2018,132(2):148-158.
|
[7] |
Owen W G, Esmon C T. Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. The Journal of Biological Chemistry, 1981,256(11):5532-5535.
|
[8] |
Anastasiou G, Gialeraki A, Merkouri E, et al. Thrombomodulin as a regulator of the anticoagulant pathway: implication in the development of thrombosis. Blood Coagulation & Fibrinolysis, 2012,23(1):1-10.
pmid: 22036808
|
[9] |
Nishizawa S, Kikuta J, Seno S, et al. Thrombomodulin induces anti-inflammatory effects by inhibiting the rolling adhesion of leukocytes in vivo. Journal of Pharmacological Sciences, 2020,143(1):17-22.
pmid: 32122774
|
[10] |
王涤非, 刘国良, 吴桂萍, 等. 糖尿病血浆血栓调节蛋白水平的测定. 中国医科大学学报, 2000,29(5):368-369.
|
|
Wang D F, Liu G L, Wu G P, et al. Measurement of soluble thrombomodulin in plasma from diabetes. Journal of China Medical University, 2000,29(5):368-369.
|
[11] |
林静, 孙志鹏, 李娟, 等. 联合检测TM、TAT、PIC、t-PAIC水平对DIC的诊断价值. 国际检验医学杂志, 2019,40(12):1413-1416.
|
|
Lin J, Sun Z P, Li J, et al. Value of combined detection of the levels of serum TM, TAT, PIC and t-PAIC for the early diagnosis of disseminated intravascular coagulation. International Journal of Laboratory Medicine, 2019,40(12):1413-1416.
|
[12] |
Luo Y Q, Liu T, Zhu J M, et al. Label-free and sensitive detection of thrombomodulin, a marker of endothelial cell injury, using quartz crystal microbalance. Analytical Chemistry, 2015,87(22):11277-11284.
|
[13] |
周齐洋, 黄建荣, 陈祥, 等. 血清淀粉样蛋白A化学发光免疫检测技术开发. 生物学杂志, 2019,36(4):85-88.
|
|
Zhou Q Y, Huang J R, Chen X, et al. Development of chemiluminescent immunoassay for human serum amyloid A. Journal of Biology, 2019,36(4):85-88.
|
[14] |
Huo J Q, Barnych B, Li Z F, et al. Hapten synthesis, antibody development, and a highly sensitive indirect competitive chemiluminescent enzyme immunoassay for detection of dicamba. Journal of Agricultural and Food Chemistry, 2019,67(20):5711-5719.
doi: 10.1021/acs.jafc.8b07134
pmid: 31042038
|
[15] |
何旭华, 徐也鲁, 王振义. 人血栓调节蛋白的分离提纯及其功能特性的初步研究. 浙江医科大学学报, 1988,17(1):1-5.
|
|
He X H, Xu Y L, Wang Z Y. Isolation and purification of human thrombomodulin and preliminary study on its functional properties. Journal of Zhejiang Medical University, 1988,17(1):1-5.
|
[16] |
周泉生, 奚晓东, 李佩霞, 等. 一组抗人血栓调节蛋白单克隆抗体的建株. 苏州医学院学报, 1991,11(4):259-261,340.
|
|
Zhou Q S, Xi X D, Li P X, et al. Establishment of a group of monoclonal antibodies against human thrombomodulin, Suzhou University Journal of Medical Science, 1991,11(4):259-261,340.
|
[17] |
Hosaka Y, Higuchi T, Tsumagari M, et al. Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin. Cancer Letters, 2000,161(2):231-240.
pmid: 11090974
|
[18] |
Horowitz N A, Blevins E A, Miller W M, et al. Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Blood, 2011,118(10):2889-2895.
|
[19] |
Chang Y J, Cheng Y W, Lin R K, et al. Thrombomodulin influences the survival of patients with non-metastatic colorectal cancer through epithelial-to-mesenchymal transition (EMT). PLoS One, 2016,11(8):e0160550.
doi: 10.1371/journal.pone.0160550
pmid: 27512995
|
[20] |
Kajioka H, Kagawa S, Ito A, et al. Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis. Cancer Letters, 2021,497:1-13.
|
[21] |
Karakas M, Baumert J, Herder C, et al. Soluble thrombomodulin in coronary heart disease: lack of an association in the MONICA/KORA case-cohort study. Journal of Thrombosis and Haemostasis, 2011,9(5):1078-1080.
|
[22] |
Nakanishi K, Masuda K, Mori N, et al. Evaluation of analytical performance of HISCL TM, a chemiluminescent enzyme immunoassay and the use of thrombomodulin as a marker for endothelial dysfunction. Rinsho byori. The Japanese Journal of Clinical Pathology, 2014,62(10):942-947.
pmid: 27526539
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|